Article
[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
Harefuah - 1 Dec 2012
Zuckerman Eli, Safadi Rifaat, Oren Ran, Shibolet Oren, Baruch Yaakov, Bruck Refael, Lurei Yoav, Kaspa Ran Tur, Abu-Mouch Saif, Shouval Daniel, Ben-Ari Ziv
Abstract excerpt
The current standard of care for the treatment of hepatitis C virus (HCV) is a combination of pegylated interferon alpha (PeglFN] -2a/2b and ribavirin for 24-48 weeks, according to the viral genotype. This treatment is associated with significant side effects and achieves sustained virologic response (SVR) in only 40%-50% of genotype 1 HCV-infected patients. The recent development of direct-acting antiviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.